供应商 · 生产商 · 发现——同类成熟企业

Advenza Global Limited

Advenza Global Limited 是一家一体化营养品公司，专注益生菌和酶的开发与交付：位于古吉拉特邦瓦皮的先进发酵设施，可满足单菌株浓缩物、定制混合料或成品配方的多样需求。公司由集团已故创始人 Laxminarayan Rathi 先生缔造——他早在 1958 年就建起印度首座酶工厂，被誉为印度酶工业之父。Advenza 于 2005 年注册成立，填补行业对货架稳定酶制剂的需求；2009 年在瓦皮建立配方工厂，2020年11月建成生物技术创新中心，2022年12月建成生物制造设施，服务全球对高质量益生菌的增长需求。公司可开发交付多种剂型：粉剂、片剂（吞服、咀嚼、分散）、胶囊、干糖浆、滴剂和混悬液……

运营中印度亚洲成立 2005 未上市员工: 92 营收: Between ₹50 Cr and ₹100 Cr (FY ending Mar 31, 2025) 核实于 2026-10-05

简介

Advenza Global Limited is an integrated nutraceutical company that develops and manufactures probiotics and enzymes for human and animal nutrition, including single-strain concentrates, customized blends, and finished private-label formulations. It operates a biotech innovation center in Mumbai and a fermentation/manufacturing unit in Vapi, Gujarat (about 60,000+ sq. ft.), and claims compliance with ISO 22000, GMP, FSSC 22000, and HACCP. Incorporated in 2005; registered/ HQ listed address: Lodha Supremus II, Thane West, Maharashtra, India. It is public unlisted and “Active” (AGM last held 30 Sep 2025; balance sheet filed 31 Mar 2025). Revenue is reported between ₹50–₹100 Cr for FY ended 31 Mar 2025, and employee count was 209 as of Apr 01 2026. No funding rounds are disclosed as raised. Latest 2025-2026 updates in the provided results are company activity/news mentions (e.g., investors/associations in 2025–2026), but the company remains active.

Sources#

行业: 食品配料, 工业化学
主题: 酶与生物催化, 益生菌与发酵菌种, 维生素、类胡萝卜素与保健活性成分
角色: 生产商 — “…l company that develops and manufactures probiotics and enzymes for human and animal nutrition, including sing…”
为何属于生物经济: Advenza Global Limited 是一体化营养品企业，专长益生菌和酶基配方的开发与制造。
发现途径: Yakult Honsha; ScaleUp Bio

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

该公司未公开其产品或服务——我们可通过引荐了解。

新闻与状态 6

2025-03 最新状态: 公司正式由 Advanced Vital Enzymes Private Limited 更名为 Advenza Global Limited。 ↗ ↗ ↗
2025-11-07 Exclusive: Agnikul raises Rs 60 Cr in Series new round
Advenza Global Ltd has invested Rs 30 crore in Agnikul Cosmos’s Series C1 funding, alongside Atharva Green Ecotech Pvt Ltd, as part of a Rs 60 crore round to support growth and working capital.
2025-04-09 PARÉ Innovations Raises USD 8.5 Mn from Advenza Global
Advenza Global Limited has invested USD 8.5 million in PARÉ Innovations (as its first funding round), valuing PARÉ at about INR 540 crore and signaling Advenza’s active participation in funding growth-stage manufacturing ventures.
2025-11-24 Artha, Advenza, others invest in Agnikul Cosmos
Advenza Global participated in Agnikul Cosmos’s new funding round, contributing to an about ₹150 crore raise that values Agnikul at roughly $500 million. This highlights Advenza’s active role in backing India’s high-tech space startups.
2025-04-13 PARÉ Innovations raises $8.5 million from Advenza Global
Advenza Global has invested in PARÉ Innovations, leading a fresh funding round of $8.5 million (₹72.9 crore) at a post-money valuation of ₹540 crore, to support PARÉ’s expansion into over 50 global markets and strengthen its presence in India.
2025-12-04 CMS INDUSLAW acts on Agnikul Cosmos $17 million pre-Series C fundraise
Advenza Global Limited is an investor in Agnikul Cosmos’ $17 million pre-Series C round.
2026-02-10 We're a new Officer – Production in Vapi, Gujarat. Apply today or share this post with your network. | Advenza Global Limited
Advenza Global Limited is hiring for an Officer – Production position in Vapi, Gujarat, and is actively seeking applicants to apply or share the post. The post was made on February 10, 2026, and has engagement from comments and reactions.

关系网络：股东、合作伙伴、同类

合作与交易 1

交易对手	Advanced Vital Enzymes Private Limited …The company officially changed its name from Advanced Vital Enzymes Private Limited to Advenza Global Limited.…

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录